Enovix Corporation (ENVX) concluded trading on Wednesday at a closing price of $8.14, with 3.27 million shares of worth about $26.62 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -3.55% during that period and on March 26, 2025 the price saw a loss of about -6.86%. Currently the company’s common shares owned by public are about 190.56M shares, out of which, 162.97M shares are available for trading.
Stock saw a price change of 0.12% in past 5 days and over the past one month there was a price change of -13.77%. Year-to-date (YTD), ENVX shares are showing a performance of -25.11% which decreased to -0.97% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.70 but also hit the highest price of $18.68 during that period. The average intraday trading volume for Enovix Corporation shares is 6.37 million. The stock is currently trading -0.82% below its 20-day simple moving average (SMA20), while that difference is down -18.79% for SMA50 and it goes to -25.47% lower than SMA200.
Enovix Corporation (NASDAQ: ENVX) currently have 190.56M outstanding shares and institutions hold larger chunk of about 48.43% of that.
The stock has a current market capitalization of $1.56B and its 3Y-monthly beta is at 1.92. It has posted earnings per share of -$1.45 in the same period. It has Quick Ratio of 5.35 while making debt-to-equity ratio of 0.79. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ENVX, volatility over the week remained 6.27% while standing at 7.35% over the month.
Stock’s fiscal year EPS is expected to rise by 7.88% while it is estimated to increase by 17.10% in next year.
Coverage by The Benchmark Company stated Enovix Corporation (ENVX) stock as a Buy in their note to investors on July 22, 2024, suggesting a price target of $25 for the stock. On December 18, 2023, William Blair Initiated their recommendations, while on July 21, 2023, TD Cowen Downgrade their ratings for the stock with a price target of $20. Stock get a Buy rating from Canaccord Genuity on January 11, 2023.
